(Z)-7-[(3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (Z)-7-[(3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid
• 化学式: C₂₁H₃₆O₅
• 分子量: 368.514
• InChiKey: DLJKPYFALUEJCK-ABNREHQVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  26
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.76
• 拓扑面积：
  98
• 氢给体数：
  4
• 氢受体数：
  5

文献信息

• Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
  申请人：THEMIS MEDICARE LIMITED

  公开号：US10940205B2

  公开（公告）日：2021-03-09

  The present invention relates to pharmaceutical compositions of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle and/or to pharmaceutical compositions utilizing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle or as a solvent system in preparation of such pharmaceutical compositions. The pharmaceutical compositions of the present invention are safe, non-toxic, exhibits enhanced physical stability compared to conventional formulations containing such pharmaceutical actives and are suitable for use as injectables for intravenous and intramuscular administration, as well as for use as a preformed solution/liquid for filling in and preparation of capsules, tablets, nasal sprays, gargles, dermal applications, gels, topicals, liquid oral dosage forms and other dosage forms.

  本发明涉及各种药物活性物质的药物组合物，特别是含有二乙二醇单乙醚或其 他烷基衍生物作为主要载体的冻干和亲水活性物质，和/或涉及利用二乙二醇单乙醚或其 他烷基衍生物作为主要载体或作为制备此类药物组合物的溶剂系统的药物组合物。本发明的药物组合物安全、无毒，与含有此类药物活性成分的传统制剂相比，具有更强的物理稳定性，适合用作静脉注射和肌肉注射的注射剂，也适合用作预制溶液/液体，用于填充和制备胶囊、片剂、鼻腔喷雾剂、漱口水、皮肤应用、凝胶、外用药、口服液剂型和其他剂型。
• COMPOSITIONS OF PHARMACEUTICAL ACTIVES CONTAINING DIETHYLENE GLYCOL MONOETHYL ETHER OR OTHER ALKYL DERIVATIVES
  申请人：THEMIS MEDICARE LIMITED

  公开号：US20140296191A1

  公开（公告）日：2014-10-02

  The present invention relates to pharmaceutical compositions of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle and/or to pharmaceutical compositions utilizing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle or as a solvent system in preparation of such pharmaceutical compositions. The pharmaceutical compositions of the present invention are safe, non-toxic, exhibits enhanced physical stability compared to conventional formulations containing such pharmaceutical actives and are suitable for use as injectables for intravenous and intramuscular administration, as well as for use as a preformed solution/liquid for filling in and preparation of capsules, tablets, nasal sprays, gargles, dermal applications, gels, topicals, liquid oral dosage forms and other dosage forms.
• US9827315B2
  申请人：——

  公开号：US9827315B2

  公开（公告）日：2017-11-28
• [EN] COMPOSITIONS OF PHARMACEUTICAL ACTIVES CONTAINING DIETHYLENE GLYCOL MONOETHYL ETHER OR OTHER ALKYL DERIVATIVES<br/>[FR] COMPOSITIONS DE PRINCIPES PHARMACEUTIQUES ACTIFS CONTENANT DE L'ÉTHER DE MONOÉTHYLE ET DE DIÉTHYLÈNEGLYCOL OU D'AUTRES DÉRIVÉS ALKYLIQUES
  申请人：THEMIS MEDICARE LTD

  公开号：WO2014178065A1

  公开（公告）日：2014-11-06

  The present invention relates to pharmaceutical compositions of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle and/or to pharmaceutical compositions utilizing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle or as a solvent system in preparation of such pharmaceutical compositions. The pharmaceutical compositions of the present invention are safe, non-toxic, exhibits enhanced physical stability compared to conventional formulations containing such pharmaceutical actives and are suitable for use as injectables for intravenous and intramuscular administration, as well as for use as a preformed solution/liquid for filling in and preparation of capsules, tablets, nasal sprays:; gargles, dermal applications, gels, topicals. liquid oral dosage forms and other dosage forms.